Mergers: Commission approves GlaxoSmithKline’s acquisition of Pfizer’s Consumer Health Business, subject to conditions

drugs

(Joshua Coleman, Unsplash)

This article is brought to you in association with the European Commission.


The European Commission has approved, under the EU Merger Regulation, the acquisition of Pfizer’s Consumer Health Business by GlaxoSmithKline. The decision is conditional upon the global divestment of Pfizer’s topical pain management business carried out under the ThermaCare brand.

GlaxoSmithKline (“GSK”) and Pfizer’s Consumer Health Business are both manufacturers and suppliers of a variety of consumer healthcare pharmaceuticals, which are typically available to patients without a prescription from a doctor and generally referred to as “over-the-counter” (“OTC”) pharmaceutical products.

Both companies are active in the European Economic Area (“EEA”) in a number of OTC product categories, namely topical pain management (creams, gels, spays and patches to treat pain locally), systemic pain management (products for oral intake targeting pain centrally), cold and flu treatments (e.g. multi-symptom treatments, antitussives), gastrointestinal treatments (e.g. antiacids, antiflatulents, antiulcerants), nutrition and digestive health (e.g. vitamins, supplements, laxatives), as well as sedatives and sleeping aids.

The Commission’s investigation

The Commission examined the effects of the proposed transaction on competition in the markets where the activities of the companies overlap.

Based on the investigation, the Commission was concerned that the acquisition would reduce competition for topical pain management products, possibly resulting in price increases in a number of EEA countries, including Austria, Germany, Ireland, Italy and the Netherlands.

In the market for topical pain management products,the Commission found products to be broadly substitutable irrespective of their different format or composition (e.g. patches and gels, medicated or not).

For topical pain management products, GSK is a leading OTC supplier in the EEA with its range of Volta-branded products (including VoltarenVoltadol, or Voltarol). These products are mainly sold as medicated gel, creams or spray but also as medicated and non-medicated patches. Pfizer is mostly active in the EEA with its range of ThermaCare-branded products, which consists mainly of non-medicated patches.

The proposed remedies

To address these concerns, the companies offered to divest Pfizer’s topical pain management business carried out under the ThermaCarebrand globally. This includes all relevant assets that contribute to the current operation or are necessary to ensure the viability and competitiveness thereof.

These assets will have to be divested as a package to one suitable purchaser to be approved by the Commission. The commitments provide in particular for the divestiture of a Pfizer manufacturing facility located in the US, which is dedicated to the production of ThermaCare products, of all intellectual property rights relating to the ThermaCare products and brand, as well as products under development.

These commitments remove almost entirely the overlaps between GSK and Pfizer’s Consumer Health Business in the topical pain management category in the EEA.

Therefore, the Commission concluded that the proposed transaction, as modified by the commitments, would no longer raise competition concerns in the EEA. The Commission’s decision is conditional upon full compliance with the commitments.

Companies and products

GSK, based in the UK, is a pharmaceuticals company active worldwide in research, development, manufacturing, and marketing in three broad segments, i.e. prescription pharmaceuticals, vaccines, and consumer healthcare products.

Pfizer, based in the US, is a pharmaceuticals company active worldwide in the research, development, manufacturing and marketing of innovative medicines. Pfizer’s Consumer Health Businessoffers products in five major areas: (a) pain management; (b) gastrointestinal health; (c) respiratory; (d) dietary supplements, and (e) personal care products (e.g. lip care).

Merger control rules and procedures

The transaction was notified to the Commission on 17 May 2019.

The Commission has the duty to assess mergers and acquisitions involving companies with a turnover above certain thresholds (see Article 1 of the Merger Regulation) and to prevent concentrations that would significantly impede effective competition in the EEA or any substantial part of it.

The vast majority of notified mergers do not pose competition problems and are cleared after a routine review. From the moment a transaction is notified, the Commission generally has a total of 25 working days to decide whether to grant approval (Phase I) or to start an in-depth investigation (Phase II). This deadline is extended to 35 working days in cases where remedies are submitted by the parties, such as in this case.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

EU finally to extend sanctions on Russia despite arguments; Greece again in Europe’s spotlight

What is the Internet of Things?

Scale of displacement across Myanmar ‘very difficult to gauge’, says UN refugee agency

EU migrant crisis: Germany, France and UK to show the way. Will the rest of the EU follow?

Global Recovery: The EU disburses SDR 141 Million to the IMF’s Catastrophe Containment and Relief Trust

Joint  EU-US Statement on  the Global Methane Pledge 

“Joining forces to #BeatPollution”, a Sting Exclusive by the Head of UNEP in Brussels

This is what CEOs around the world see as the biggest risks to business

How scientists are turning living cells into the tiny factories of the future

COVID-19 is threatening the lives of migrant children held in US custody

The COVID-19 recovery can be the vaccine for climate change

At G20 Summit OECD’s Gurría says collective action vital to tackle global challenges

UN rights chief ‘appalled’ by US border detention conditions, says holding migrant children may violate international law

Why trade wars have no winners

GSMA Announces Final Event Lineup for Highly Anticipated 2019 “MWC Los Angeles, in Partnership with CTIA”

EU leading in global agri-food trade

Member States’ compliance with EU law in 2018: efforts are paying off, but improvements still needed

The widely advertised hazards of the EU not that ominous; the sting is financial woes

South Korea once recycled 2% of its food waste. Now it recycles 95%

MEPs adopt Technical Support Instrument to speed up post-COVID-19 recovery

MEPs demand end to EU arms exports to Saudi Arabia

The ECB ‘accidentally’ followed IMF‘s policy advice for growth and job creation by printing more money

Brexit: European Commission publishes Communication on preparing for the UK’s withdrawal from the EU

The gender gap of medicine in 2018

Why our future relies on more inclusive and transparent innovation

What’s behind South Korea’s elderly crime wave?

European Commissioner for Youth wants young people to be at heart of policy making

EU: All economic indicators in free fall

Stop wars disguised as peace missions

Young translators at EU schools – Commission opens registration for 2020 translation contest

Social, cultural diversity ‘an enormous richness, not a threat’ Guterres declares calling on investment for a harmonious future

ECB money bonanza not enough to revive euro area, Germany longs to rule with stagnation

Five avoidable deaths per minute shows urgent need for action on patient safety

Towards a seamless internal EU market for industrial goods

Digital Green Certificate is the right move but speeding up vaccination is key

Myanmar doing too little to ensure displaced Rohingya return: UN refugee agency chief

Brexit: UK business fear of a no-deal scenario preparing for the worst

How man and machine can work together in the age of AI

MWC 2016 LIVE: Orange targets VoLTE and Voice over Wi-Fi; strikes Google partnership

75 years after Auschwitz liberation, antisemitism still threatens ‘foundations of democratic societies’

UNESCO food and culture forum dishes up fresh serving of SDGs

European markets itchy with short-term disturbances

Bioethics: how to recover trust in the doctor-patient relationship

This Kenyan company makes fuel from human poo

“Healthcare system and socioeconomic inequities”-through the lens of developing nations

China repels EU allegations of export subsidies

Germany’s fiscal and financial self-destructive policies

Cameron readies to support ‘yes’ for Britain in the EU

How Bangladesh’s leaders should respond to the economic threats of COVID-19

Civil protection: Parliament strengthens EU disaster response capability

Where are fleeing Afghans finding refuge?

Why the 33,000 staff European Commission did not have a real contingency plan for the refugee crisis?

MEPs approve the EU’s new culture programme

Human Rights breaches in Russia, Afghanistan and Burkina Faso

From raised fists at the 1968 Olympics to taking the knee: A history of racial justice protests in sport

Trump’s Russian affair spills over and upsets Europe

Why is Merkel’s Germany so liberal with the refugees? Did the last elections change that?

MEPs vote for upgrade to rail passenger rights

Mobile technology saving lives: changing healthcare with simple technology solutions

European Defence Fund on track with €525 million for Eurodrone and other joint research and industrial projects

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: